• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[咖啡因作为帕金森病的预防药物:流行病学证据与实验支持]

[Caffeine as a preventive drug for Parkinson's disease: epidemiologic evidence and experimental support].

作者信息

Góngora-Alfaro José Luis

机构信息

Universidad Autonoma de Yucatan, Merida, Mexico.

出版信息

Rev Neurol. 2010;50(4):221-9.

PMID:20198594
Abstract

INTRODUCTION AND DEVELOPMENT

Prospective epidemiologic studies performed in large cohorts of men (total: 374,003 subjects) agree in which the risk of suffering Parkinson's disease diminishes progressively as the consumption of coffee and other caffeinated beverages increases. In the case of women (total: 345,184 subjects) the protective effect of caffeine is only observed in menopausal women which do not receive estrogen replacement therapy. Studies with models of acute parkinsonism in rodents have shown that caffeine reduces the loss of nigrostriatal dopaminergic neurons induced with the neurotoxins 6-hidroxidopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, effect that seems to be mediated through blockade of A(2A) adenosine receptors. Recently, it was shown that male rats treated with moderate doses of caffeine (5 mg/kg/day) during six months, followed by a withdrawal period of at least two weeks, developed a greater resistance to the catalepsy induced with the dopaminergic antagonist haloperidol, which was possibly mediated by an increase of dopaminergic transmission in the corpus striatum.

CONCLUSIONS

More studies are needed to demonstrate unequivocally that caffeine prevents the degeneration of dopaminergic neurons in animal models of moderate, chronic, and progressive parkinsonism, since it could lead to the discovery of more effective drugs for the prevention of aging-related degenerative diseases of the central nervous system.

摘要

引言与发展

在大量男性队列(总计374,003名受试者)中进行的前瞻性流行病学研究一致表明,帕金森病的患病风险会随着咖啡和其他含咖啡因饮料摄入量的增加而逐渐降低。对于女性(总计345,184名受试者)而言,咖啡因的保护作用仅在未接受雌激素替代疗法的绝经后女性中观察到。对啮齿动物急性帕金森病模型的研究表明,咖啡因可减少由神经毒素6 - 羟基多巴胺和1 - 甲基 - 4 - 苯基 - 1,2,3,6 - 四氢吡啶诱导的黑质纹状体多巴胺能神经元的损失,这种作用似乎是通过阻断A(2A)腺苷受体介导的。最近,研究表明雄性大鼠连续六个月接受中等剂量咖啡因(5毫克/千克/天)治疗,随后至少停药两周,对多巴胺能拮抗剂氟哌啶醇诱导的僵住症具有更强的抵抗力,这可能是由纹状体中多巴胺能传递增加介导的。

结论

需要更多研究来明确证明咖啡因可预防中度、慢性和进行性帕金森病动物模型中多巴胺能神经元的退化,因为这可能会促成发现更有效的药物来预防与衰老相关的中枢神经系统退行性疾病。

相似文献

1
[Caffeine as a preventive drug for Parkinson's disease: epidemiologic evidence and experimental support].[咖啡因作为帕金森病的预防药物:流行病学证据与实验支持]
Rev Neurol. 2010;50(4):221-9.
2
Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.长期用咖啡因处理的雄性大鼠对氟哌啶醇诱导的僵住症产生持久抗性。
Neurosci Lett. 2009 Oct 9;463(3):210-4. doi: 10.1016/j.neulet.2009.07.084. Epub 2009 Aug 3.
3
Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease.咖啡因和腺苷A(2A)受体拮抗剂在帕金森病动物模型中的新型神经保护作用
J Neurol Sci. 2006 Oct 25;248(1-2):9-15. doi: 10.1016/j.jns.2006.05.003. Epub 2006 Jun 27.
4
Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum.咖啡因对正常及1-甲基-4-苯基-1,2,3,6-四氢吡啶处理的小鼠纹状体中细胞色素P450 1A2、腺苷A2A受体和多巴胺转运体表达的影响。
Brain Res. 2009 Aug 4;1283:115-26. doi: 10.1016/j.brainres.2009.06.002. Epub 2009 Jun 9.
5
Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease.尼古丁和咖啡因对帕金森病神经保护作用的当前证据。
Drugs Aging. 2001;18(11):797-806. doi: 10.2165/00002512-200118110-00001.
6
Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence.咖啡因对大鼠帕金森病模型神经退行性变的保护作用:行为学和组织化学证据。
Parkinsonism Relat Disord. 2004 Dec;10(8):465-8. doi: 10.1016/j.parkreldis.2004.06.004.
7
Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.雌激素、神经炎症与帕金森病中的神经保护:神经胶质细胞决定对神经退行性变的抵抗与易感性
Neuroscience. 2006;138(3):869-78. doi: 10.1016/j.neuroscience.2005.07.060. Epub 2005 Dec 5.
8
Treatment with subthreshold doses of caffeine plus trihexyphenidyl fully restores locomotion and exploratory activity in reserpinized rats.用阈下剂量的咖啡因加苯海索治疗可完全恢复利血平化大鼠的运动和探索活动。
Neurosci Lett. 2004 Sep 9;367(3):327-31. doi: 10.1016/j.neulet.2004.06.022.
9
Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse.尼古丁和咖啡因介导的对1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的小鼠帕金森病表型中毒物反应基因和囊泡单胺转运体-2表达的调节。
Brain Res. 2008 May 1;1207:193-206. doi: 10.1016/j.brainres.2008.02.023. Epub 2008 Feb 21.
10
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.帕金森病1-甲基-4-苯基-1,2,3,6-四氢吡啶/丙磺舒渐进性神经退行性小鼠模型黑质致密部神经元凋亡的早期迹象。
Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14.

引用本文的文献

1
Herniarin, Dimethylfraxetin and Extracts from , in Psychosis Secondary to Ketamine and Its Interaction with Haloperidol.蛇床子素、二甲基牛蒡子苷元以及[具体植物名称]提取物在氯胺酮所致精神障碍中的作用及其与氟哌啶醇的相互作用
Plants (Basel). 2022 Oct 21;11(20):2789. doi: 10.3390/plants11202789.
2
Systemic Oxidative Stress: A key Point in Neurodegeneration - A Review.系统性氧化应激:神经退行性变的关键——综述。
J Nutr Health Aging. 2019;23(8):694-699. doi: 10.1007/s12603-019-1240-8.
3
Nutraceuticals in Parkinson's Disease.帕金森病中的营养保健品
Neuromolecular Med. 2016 Sep;18(3):306-21. doi: 10.1007/s12017-016-8398-6. Epub 2016 May 4.
4
Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM.全基因组关联分析表明,喝咖啡与 CYP1A1/CYP1A2 和 NRCAM 有关。
Mol Psychiatry. 2012 Nov;17(11):1116-29. doi: 10.1038/mp.2011.101. Epub 2011 Aug 30.
5
The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.营养保健品策略减轻帕金森病神经退行性变的生化和细胞基础。
Int J Mol Sci. 2011 Jan 17;12(1):506-69. doi: 10.3390/ijms12010506.